Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye
Figure 5
A 61-year-old male showed CNV (arrows) due to AMD (a). Fluorescein angiography (FA) showed predominantly classic CNV (c), and optical coherence tomography (OCT) revealed a subretinal lesion before treatment (e). After the oral administration of alendronate for three months, the CNV regressed remarkably (b) and no leakage was observed using FA (d). A remarkable decrease in the size of the subretinal lesion was observed using OCT (f).
